You are here

Vascular & Endovascular

 - blood clot, platelets, vein

Anticoagulation won and retrievable inferior vena cava filters lost in a randomized clinical trial that assessed their benefit and risk in patients at a high risk of a recurrence of pulmonary embolism. Improvements in the former may have leveled the playing field.

 - Myocardial Infarction

After a median follow-up of more than 20 years, researchers found an increased risk of non-ST elevation myocardial infarction (non-STEMI) in patients with atrial fibrillation even when adjusting for cardiovascular and other risk factors. However, there was no association between atrial fibrillation and STEMI.

 - bleeding_stroke

Patients with acute ischemic stroke had a reduction in the severity of disability and an increase in functional independence after they received mechanical thrombectomy with the Solitaire stent retriever, according to a multicenter, prospective, randomized trial.

 - carotid plaque

For patients undergoing elective carotid artery stenting, in-hospital and 30-day stroke and death rates were similar if they received proximal embolic protection devices or distal filter embolic protection devices, according to a study that compared the efficacy of the devices.

 - brain, stroke

From 2001 to 2011, the rate of emergency department visits for ischemic stroke or transient ischemic attack (TIA) among adults decreased 35 percent, while the percentage of visits that resulted in admission or transfer to a hospital increased 10 percent.


More Stories

Review finds fewer DVT hospitalizations with rivaroxaban

Researchers comparing patients given rivaroxaban or low-molecular weight heparin in a hospital setting found that use of rivaroxaban correlated to a 27 percent reduction in hospital admissions among patients with deep vein thrombosis (DVT).

Pharmacist-physician teams improve patients' blood pressure control

Multidisciplinary teams offer a broader scope of clinical opinions that can change the face of healthcare. In the case of physician-pharmacist teams, blood pressure control at nine months was best among patients monitored by a team, with sustained improvement through 24 months among minorities.

Poor showing for intracranial stent vs. medical therapy … again

For symptomatic intracranial stenosis, aggressive medical therapy appears the best choice. Again. According to the findings from VISSIT, patients receiving intracranial stents were more than twice as likely to have a stroke, transient ischemic attack, intracranial hemorrhage or die within the first 30 days.

Watchman prevails at last, getting FDA's OK

Boston Scientific’s implantable Watchman Left Atrial Appendage Closure Device finally won FDA approval to become an option to long-term warfarin therapy for high-risk patients with nonvalvular atrial fibrillation.

Taking a 5,000-mile ride for stroke prevention

Former Intel executive Sean Maloney set off on a 5,000-mile cycling quest March 22 to raise awareness about stroke prevention. His Heart Across America campaign is a three-month fundraising trek from Palo Alto, Calif., to New York City.

When no statin is best: Reassessing meds at end of life

Sometimes eliminating a drug may be the best way to care for a dying patient. Findings comparing continued and terminated statin therapy in palliative care patients found those who discontinued statins experienced improved quality of life with no significant increase in risk of death.

FDA adds Protégé to list of approved iliac stents

The FDA approved a self-expanding stent system for patients with peripheral artery disease, adding another option for treating blockages in the iliac arteries.

A Stroke of Genius: Gains Seen on Many Fronts at Meeting

The American Stroke Association’s 2015 International Stroke Conference held Feb. 11-13 in Nashville, Tenn., likely lifted many spirits with findings that supported new therapies and identified opportunities to improve patient care.

2014 guidelines greatly expand oral anticoagulation’s ranks

Adopting 2014 guidelines for reducing the risk of stroke in patients with atrial fibrillation would revise the number recommended for oral anticoagulation treatment in the U.S. upwards by 988,500, according to an analysis published online March 2 in JAMA Internal Medicine.

Poor response to statins may signal progression in blocked arteries

Lowered response to statin therapy may indicate more rapidly progressive atherosclerosis, according to a meta-analysis. These patients, representing one-fifth of the study population, were more likely to have significant arterial blockage progression at follow-up than those who responded to treatment.

Men, women with AF get similar but inadequate thromboprophylaxis care

Man or woman, prescription rates for stroke-preventing anticoagulants were no different for patients with nonvalvular atrial fibrillation (AF) in a global study. However, on the whole the same anticoagulation rates showed inadequate thromboprophylaxis in the majority of patients.

CMS allows add-on payments for drug-coated balloons

The Centers for Medicare & Medicaid Services (CMS) has approved supplemental reimbursement for two drug-coated balloons to treat Medicare patients with peripheral artery disease, but the payment applies only to outpatient settings.

FDA recalls two Trellis peripheral devices

The FDA has made a voluntary recall of two peripheral infusion systems into a Class 1 recall.

Progress with stroke

The recent stroke conference highlighted a score of advancements, proof of the commitment and creativity devoted to this complex condition.

ISC.15: TNK tPA as alternative to alteplase appears safe, feasible

Even a minor stroke can lead to disability if paired with an intracranial occlusion. Researchers explored the use of tenecteplase (TNK) tissue-type plasminogen activator (tPA) to safely treat this type of stroke before it progressed.

ISC.15: Just add water? Hydration may help turn tide in stroke care

Could something as simple as water create a sea change in stroke care? A study unveiled Feb. 12 pointed to dehydration as a factor in poor stroke outcomes, making rehydration a possible pathway for improvement, the lead researcher told Cardiovascular Business

ISC.15: Stent thrombectomy pulls ahead of alteplase alone in ischemic stroke

Providing more proof that time is brain, a randomized trial found that promptly performing thrombectomy with a stent retriever in carefully selected ischemic stroke patients led to better outcomes than did alteplase treatment alone.

ISC.15: Vitamin D may predict stroke severity

Physicians, take note: Researchers may have found a link between stroke severity and vitamin D deficiency. These findings were presented Feb. 11 at the American Stroke Association’s 2015 International Stroke Conference in Nashville, Tenn.

ISC.15: Functional stroke outcomes improved by rapid endovascular treatment

For some patients with acute ischemic stroke, rapid endovascular treatment may offer improved outcomes, according to findings presented Feb. 11 at the American Stroke Association’s 2015 International Stroke Conference (ISC) in Nashville, Tenn.

FDA opens door for transcarotid stenting system

The FDA paved the way for use of a neuroprotection and stent system that allows access to diseased carotid arteries through the neck rather than the femoral artery.